SSSevil Sayhan

Sevil Sayhan

*This is an algorithmically generated author record based on publicly available information.

Sevil Sayhan has a total of 36 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Stage-dependent expression and nuclear localization of EZH2 in endometrial carcinogenesis: evidence from cell lines and human tissues

    by Oya Korkmaz, Işıl Aydemir, Elgin Turkoz Uluer, Muzaffer Sancı, Gulden Diniz, Sevil Sayhan, Sevinç İnAn

  • Open Access

    ENDOMETRİAL KANSERLERİN İNTRAOPERATİF DEĞERLENDİRİLMESİNİN GÜVENİLİRLİĞİ

    by Sevil Sayhan, Ayşe Gül TAVUKÇU, Duygu Ayaz, Gamze Aköz, Esra Canan Kelten Talu, Tuğba KARADENİZ

    Amaç: Endometrial kanser gelişmiş ülkelerde jinekolojik maligniteler arasında ilk sıradadır. Bilateral salpingooferektomiyle birlikte total histerektomi; erken evre endometrial karsinomlarda standart tedavidir. Histolojik tip, myometrial invazyon, tümörün histolojik derecesi ve servikal tutulum ek cerrahi prosedürleri gerektirir. Patoloğun intraoperatif tanısı bu süreçte yol göstericidir. Bu çalışmanın amacı; laboratuvarımızda, endometrial karsinomun evreleme cerrahi prosedürü sırasında intraoperatif frozen tanının güvenilirliğini değerlendirmektir. Gereç ve Yöntem: Çalışmamızda 2019 ocak ayı ile 2022 nisan ayı arasında, endometrial karsinom ve atipili endometrial hiperplazi ön tanısı ile frozen çalışılan olguların hepsi taranmış olup; 212 olgudan, frozen raporlarına ulaşılabilen 151 olgu değerlendirilmeye alınmıştır. Histolojik tip ve derece, tümör çapı, myometrial invazyon, servikal ve adneksiyal tutulum; frozen ve parafin kesitlerinde retrospektif olarak değerlendirilmiştir. Tümör çapı <2 cm ve ≥2 cm olarak , myometrial invazyon ise %50’den yüzeyel ve %50’den derin olarak kategorize edilmiştir. Bulgular: Frozen kesitlerin parafin kesitlerle uyumluluğu; histolojik tip için %98.6, histolojik derece için %74.8, myometriyal invazyon için %82.8, tümör çapı için %90.7, servikal invazyon için %91.4 ve over metastazı için %99.3 olarak bulunmuştur. Sonuç: Bölümümüzde uygulanan endometrial kanserlerin intraoperatif frozen tanı sonuçları, parafin tanı sonuçları ile büyük oranda uyumludur. Bu durum şimdiye kadar ortaya konan ilgili literatür ile benzerlik göstermektedir. Sonuçta hastaların morbiditesi yüksek olan gereksiz lenfadenektomiye maruz kalmaması için intraoperatif frozen prosedürü gerekli ve güvenilir bir uygulamadır. Aim: Endometrial cancer is the most common gynecological malignancies in developed countries. Total hysterectomy with bilateral salpingoophorectomy is the standard treatment for early stage endometrial carcinomas. Histological type, myometrial invasion, histological grade of tumor, and cervical involvement require additional surgery. The pathologist’s intraoperative diagnosis provides guidance in this process. The aim of this study is to assess the reliability of intraoperative frozen diagnosis in our laboratory during surgical operations for staging endometrial carcinoma. Materials and Methods: We screened all cases between January 2019 and April 2022, which we applied frozen sectioning with preliminary diagnosis of endometrial carcinoma and endometrial hyperplasia with atypia. Out of 212 cases, we focused on 151, whose frozen section reports were accessible. Histological type and grade, tumor diameter, myometrial invasion, cervical and adnexal involvement were evaluated retrospectively in frozen and paraffin sections. Tumor diameter was categorized as <2 cm and ≥2 cm, myometrial invasion was categorized as more superficial than 50% and deeper than 50%. Results: Compatibility of frozen sections with paraffin sections are found as 98.6% for histological type, 74.8% for histological grade, 82.8% for myometrial invasion, 90.7% for tumor diameter, 91.4% for cervical invasion, and 99.3% for ovarian metastasis. Conclusion: The results of intraoperative frozen diagnosis of endometrial cancers performed in our department are largely consistent with the results of paraffin diagnosis. This result is concordant with what has been shown in the literature. Intraoperative frozen procedure is necessary and reliable to avoid unnecessary lymphadenectomy in patients with high morbidity.

  • Overin nadir tümörü: Sklerozan stromal tümör; 7 olgu sunumu ve literatürün gözden geçirilmesi

    by Duygu Ayaz, Sevil Sayhan, Tuğba KARADENİZ, Sibel Demi̇r Keçeci̇, Gamze Aköz

    Sklerozan stromal tümörler (STT), genellikle yaşamın 2-3. dekadında genç kadınlarda görülen nadir benign over tümörleridir. Over stromal tümörlerinin %2-6’sını oluştururlar. Çalışmamızda, İzmir Tepecik Eğitim ve Araştırma hastanesi patoloji bölümünde 2011-2020 yılları arasında tanı alan 7 sklerozan stromal tümör olgusunu, klinik ve histopatolojik bulgularını tekrar gözden geçirerek literatür eşliğinde sunduk . Hastalarımızın yaş ortalaması 34.4 olup 2 hasta postmenopozal dönemdeydi. Olguların 4’ünün klinik takibi mevcut olup 1 hastada operasyondan 7 yıl sonra nüks görüldü. Makroskopik olarak tümörlerin çoğu tamamıyla solid görünümdeydi. Mikroskopik olarak tüm olgularda ödemli ve /veya kollojenden zengin hiposellüler alanlarla ayrılan hipersellüler alanlardan oluşan psödolobüler düzenlenim mevcuttu. Tümör, iğsi şekilli hücreler ve bol berrak – eozinofilik şekilli yuvarlak hücrelerden oluşuyordu. Çok nadir görülmeleri nedeniyle SST de preoperatif tanı mümkün değildir. Özellikle frozen çalışılan olgularda tipik histopatolojik bulgularla doğru tanı konulması, genç kadın hastalarda fertilite koruyucu cerrahinin uygulanabilmesi açısından önem taşır.

  • Open Access

    The prognostic significance of the heterologous component in uterine carcinosarcomas

    by Behzat Can, Volkan Karataşli, İlKer Çakir, Sevil Sayhan, Kemal Hansu, Oğuzhan Kuru

    Uterine carcinosarcomas are aggressive, rare biphasic tumors with malignant epithelial and malignant sarcomatous components. The prognostic significance of the presence of extrauterine sarcoma (heterologous component) is controversial. Therefore, the aim of this study was to investigate the effect of heterologous components in uterine carcinosarcomas on disease-free survival, overall survival, and other prognostic factors.


  • Tissue Expression of Neutrophil Gelatinase-Associated Lipocalin and Kidney Injury Molecule-1 in Breast Cancers

    by Gülden Diniz, Ayşe Gül Pulular, Dudu Solakoğlu Kahraman, Umut Varol, Sevil Sayhan, Duygu Ayaz, Cem Karaali

    Breast cancer is the most common cancer among women worldwide. Neutrophil gelatinase-associated lipocalin (NGAL) has important roles in immunity, cell proliferation, and carcinogenesis. Kidney injury molecule-1 (KIM-1) is a transmembrane glycoprotein also known as hepatitis A virus cellular receptor 1 and T-cell immunoglobulin and mucin, has restricted expression in immune cells and healthy epithelial cells, but it is up-regulated in several human cancers. The aim of this study was to determine the prognostic values of NGAL and KIM-1 expression in tumor cells and to detect the presence of NGAL-positive neutrophils (PNL) in the tumor microenvironment. The expression of NGAL and KIM-1 protein were assessed by immunohistochemical staining in tissue specimens from 412 primary breast cancer cases. In this series, the mean age of the patients was 55.6±12.4 years. In 218 (52.9%) cases, there was NGAL expression in tumor cells. In 104 (25.2%) cases there was KIM-1 expression in tumor cells. NGAL-positive inflammatory cells were seen in tumors of 45 (10.9%) cases. There was no significant relationship between NGAL-positive PNL presence in the tumor microenvironment and other clinicopathological features. However, there was a significant association between the presence of in situ carcinomas and NGAL expression (p = 0.008) and KIM-1 expression (p = 0.020) in tumor cells. This study has demonstrated positivity of NGAL and KIM-1 in breast cancer cells. Considering the development of anti-KIM-1 therapies, the presence of KIM-1 expression may be a new treatment option in breast cancer, especially in in situ component-rich tumors. These findings should be confirmed in larger series.


  • Analysis of vanishing endometrial cancer by pathological types

    by Gökşen Görgülü, Emel Doğan Özdaş, Erol Özdaş, Sevil Sayhan, Oğuzhan Kuru, Mehmet Gökçü, Muzaffer Sancı

    Purpose We asked why endometrial cancer sometimes vanishes. Methods A total of 454 patients diagnosed with endometrioid-type endometrial cancer (EC) (via endometrial sampling) and treated in our clinic over the past 5 years were enrolled. The patients were divided into two groups: vanishing and residual, depending on whether a tumor was detected in the postoperative hysterectomy specimen. Patient age, numbers of pregnancies and deliveries, menopausal status, systemic disease status, hemogram parameters, International Federation of Gynecology and Obstetrics (FIGO) grade, and invasion status (evident on magnetic resonance imaging [MRI]) were compared between the groups. Results ECs vanished in 42 (9.25%) patients. The vanishing rates were 19.7% (37/187) in FIGO grade 1 patients, 2.1% (5/238) in grade 2 patients, and 0% (0/29) in grade 3 patients. The average age was lower in the vanishing than the residual group, but the premenopausal status and grade 1 tumor rates were higher (both p < 0.001). An absence of invasion (as revealed by MRI) was more common in the vanishing group (p < 0.001). No recurrence developed in the vanishing group, but recurrences were noted in 3.3% (14/412) of the residual group. There were no significant between-group differences in any of the numbers of pregnancies or births, systemic disease status, or hemogram parameters (all p > 0.05). Conclusion Vanishing EC is more likely in premenopausal women with endometrioid grade 1 EC (as revealed by endometrial biopsy) who lack myometrial invasion on MRI.

  • Prognostic factors in vulvar cancer patients: a single center experience

    by Gülşah Selvi̇ Demi̇rtaş, Fatih Di̇nçer, Gökşen Görgülü, Muzaffer Sanci, Sevil Sayhan

    Purpose: Many prognostic factors have been investigated in vulvar cancer patients. In our study, we aimed tocompare clinical and pathological prognostic factors and investigate the factors that affect the recurrence andsurvival in patients with recurrent and non-recurrent squamous cell vulvar cancer.Materials and methods: This retrospective study was conducted in Tepecik Research Hospital, Izmir, Turkeybetween 1999-2020. The descriptive features, prognostic factors and survival in recurrent patients wereevaluated.Results: Tumor invasion depth, surgical margin positivity, lymphovascular space invasion (LVSI), arestatistically significant for recurrence (p=0.03, p=0.00, p=0.04). Variables such as age, tumor size, surgicalmargin distance (mm), tumor localization, presence of metastatic lymph node, operation type (surgery withlymph node dissection) and adjuvant therapy were not found to be statistically significant in terms of recurrentpatients with vulvar cancer. There was correlation between recurrence, LVSI, surgical margin positivity, stageand survival in Kaplan Meier survival analysis.Conclusion: As in other studies, many prognostic factors like tumor invasion depth, surgical margin positivity,LVSI are risk factors for recurrence in our study. Stage, LVSI, recurrence, surgical margin positivity weresignificant factors for survival as well. Amaç: Vulvar kanserli hastalarda birçok prognostik faktör araştırılmıştır. Çalışmamızda nüks ve nüks olmayan skuamöz hücreli vulvar kanserli hastalarda klinik ve patolojik prognostik faktörleri karşılaştırmayı, nüks ve sağkalımı etkileyen faktörleri araştırmayı amaçladık. Gereç-Yöntem: Bu prospektif çalışma 1999-2020 yılları arasında İzmir, Tepecik Araştırma Hastanesi’nde yapıldı. Tekrarlayan hastalarda tanımlayıcı özellikler, prognostik faktörler ve sağkalım değerlendirildi. Bulgular: Tümör invazyon derinliği, cerrahi sınır pozitifliği, lenfovasküler boşluk invazyonu (LVSI) nüks açısından istatiksel olarak anlamlıdır(p=0,03, p=0,00, p=0,04). Yaş, tümör boyutu, cerrahi sınır mesafesi (mm), tümör lokalizasyonu, metastatik lenf nodu varlığı, operasyon tipi (lenf nodu diseksiyonlu cerrahi) ve adjuvan tedavi gibi değişkenler nüks vulvar kanseri hastaları açısından istatiksel olarak anlamlı bulunmadı. Kaplan Meier sağkalım analizinde nüks, lenfovasküler boşluk invazyonu, cerrahi sınır pozitifliği, evre ve sağkalım arasında korelasyon vardı. Sonuç: Diğer çalışmalarda olduğu gibi bizim çalışmamızda da tümör invazyon derinliği,cerrahi sınır pozitifliği, lenfovasküler boşluk invazyonu gibi birçok prognostik faktör nüks için risk faktörüdür. Evre, lenfovasküler boşluk invazyonu, nüks, cerrahi sınır pozitifliği de sağkalım için önemli faktörlerdendir.

  • Uterus Adenosarkomları: On Üç Olgunun Klinikopatolojik Değerlendirmesi

    by Duygu Ayaz, Sevil Sayhan, Dudu Solakoğlu Kahraman, Volkan Karataşli

    Uterus Adenosarkomları: 13 olgunun klinikopatolojik değerlendirmesi AMAÇ:Müllerian adenosarkomlar, çoğunlukla uterusta görülen, benign epitelial ve malign mezenkimal komponentten oluşan nadir bifazik tümörlerdir.Bu çalışmada uterus adenosarkomlarının klinik ve histopatolojik özelliklerini gözden geçirmeyi amaçladık. GeREÇ VE YÖNTEMLER:.Çalışmamızda, 1 Ocak 2009-1 Ocak 2020 tarihleri arasında tanı alan uterus adenosarkom olgularının klinik verileri tıbbi kayıtlar gözden geçirilerek elde edildi. Patoloji speysmenleri ise tekrar incelendi. BULGULAR: Hastanemizde tanı alan, tedavi takibi yapılan 13 uterin adenosarkom olgusunu çalışmaya dahil ettik.Tümörlerin tümünün endometriumdan köken aldığı izlenirken hastaların %69.2’si tanı anında 1. evredeydi. Hastaların %69.3’ünde evreleme yapıldı.Olguların %69.2’sinde mezenkimal komponenet yüksek dereceli olup tümünde sarkomatöz aşırı büyüme dikkati çekti.SONUÇ: Literatürle uyumlu olarak sarkomatöz aşırı büyüme, derin myometrial invazyon ve heterolog komponent varlığının, kısa sağkalım süreleriyle ilişkili olduğunu saptadık. Anahtar sözcükler: Müllerian adenosarkom, uterus, sarkomatöz aşırı büyüme Uterine Adenosarcoma: Clinicopathological evaluation of 13 cases OBJECTIVE: Mullerian adenosarcomas are rare biphasic tumors mostly seen in the uterus, consisting of benign epithelial and malignant mesenchymal components. In this study, we aimed to review the clinical and histopathological features of uterine adenosarcoma. MATERIAL AND METHODS: In our study, clinical data of ureus adenosarcoma cases diagnosed between 1 January 2009 and 1 January 2020 were obtained by reviewing medical records. Pathology speysmenelri were examined again. RESULTS. We included 13 uterine adenosarcoma cases diagnosed in our hospital and followed-up. While all tumors originated from the endometrium, 69.2% of the patients were in the first stage at the time of diagnosis. Staging was performed in 69.2% of patients. Mesenchymal component was high in 69.2% of cases, and sarcomatous overgrowth was noted in all. CONCLUSION: In accordance with the literature, we found that the presence of sarcomatous overgrowth, deep myometrial invasion and heterologous component was associated with short survival times. Keywords: Mullerian adenosarcoma, uterus, sarcomatous overgrowth

  • Loss of Nuclear ARID-1A Expressions Is Associated with Hormone Receptor Status in Breast Cancers

    by Melek Uncel, Gulden Diniz, Gamze Akoz, Zubeyde Yildirim Ekin, Sevil Saydan, Serdar Yardim, Semra Salimoglu

    Breast cancer is the most common cancer among women worldwide. Adenine thymine-rich interactive domain 1A (ARIDIA) is a tumor suppressor gene involved in chromatin remodeling and it encodes the ARIDIA protein. Recent studies have shown the loss of ARIDIA protein expression in different carcinomas may have a prognostic significance. In the present study, we aimed to evaluate the interactions between ARIDIA loss and molecular subtypes of breast carcinomas. ARIDIA expressions were studied in 292 formalin- fixed, paraffin- embedded breast carcinoma specimens and its association with different pathological and clinical parameters was evaluated. Loss of ARIDIA expression was detected in 123 cases. There was no statistically significant association between ARID-1A expression and molecular subtype of breast carcinomas (p=0.110) or HER2 amplification (p=0.909). Contrarily, there was a significant association between ARIDIA expression and presence of estrogen (p=0.047) or progesterone receptors (p=0.023). Besides a statistically significant relationship was found between loss of ARID1A, and the presence of both in situ component (p=0.016) and lymph node metastasis (p=0.001). In this study, we have demonstrated that loss of ARID1A expression positively correlates with hormone receptor status as well as tumor aggressiveness.